Balloon Catheter

This channel includes news and new technology innovations for angioplasty balloon catheters (PTA). These are used in arteries with atherosclerotic lesions to compress the plaque expand the artery lumen to reopen occluded or heavily stenosed atherosclerotic lesions. Balloons are often used in combination with a stent to prop the treated vessel segment open. In addition to plain old balloon angioplasty (POBA), this section includes news about drug-coated balloon (DCB), valvuloplasty balloons and specialty cutting balloon.

Shockwave Medical, Lithoplasty, $40 million, funding, Sofinnova, Venrock
Feature | May 27, 2015
May 27, 2015 — Shockwave Medical announced $40 million in funding, co-led by returning investor Sofinnova Partners and...
IN.PACT Admiral, Global Study, DEB SFA-LONG, long peripheral lesions, EuroPCR
News | May 22, 2015
May 22, 2015 — New clinical data from two different studies show the IN.PACT Admiral drug-coated balloon from Medtronic...
Medtronic, Euphora, SC, semicompliant balloon dilatation catheter, FDA, U.S.
Technology | May 08, 2015
May 8, 2015 — Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance and U.S. launch of the...
Stellarex, Spectranetics, investment, BTK, peripheral artery disease
News | May 06, 2015
May 6, 2015 — The Spectranetics Corporation announced it is accelerating investments in the Stellarex drug-coated...
Videos | Drug-Eluting Balloons | April 02, 2015
In 2015, the FDA approved the first two drug-coated balloons for the U.S. market to treat peripheral artery disease in...
Videos | Cath Lab | March 25, 2015
Hear the latest trends and news on interventional cardiology from the American College of Cardiology (ACC) 2015 meeting...
Biotronik, Passeo-18 Lux, DCB, BIOLUX P-I, trial, drug eluting, balloon catheter
News | March 04, 2015
March 4, 2015 — Biotronik announced that results of its BIOLUX P-I clinical study have been published in the Journal of...
Feature | March 02, 2015
March 2, 2015 — Cardinal Health announced plans to acquire Johnson & Johnson’s Cordis business, a leading global...
In.PACT Admiral, PAD, Medicare, pass-through payment, Medtronic, balloon cath
News | February 23, 2015
February 23, 2015 — Medtronic announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a...
Bard, Lutonix, drug coated balloon, DCB, CMS, pass-through payment, outpatient
News | February 23, 2015
February 23, 2015 — C. R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has...
Lutonix, drug eluting balloon, drug coated balloon

The Bard Lutonix drug-eluting balloon was the first DEB to gain FDA approval in October 2014. Illustration by Mike Austin. Copyright 2015. All Rights Reserved.

Feature | February 19, 2015 | Dave Fornell
Drug-eluting balloons (DEBs), also referred to as drug-coated balloons (DCBs), have been one of the long-awaited new...
Boston Scientific, Bard, Lutonix, DCB, drug coated balloon, distribute
News | February 13, 2015
February 13, 2015 — Boston Scientific and C. R. Bard announced a deal where Boston Scientific will distribute the...
Medtronic, In.Pact Admiral DCB, PAD, U.S. launch, drug-coated balloon
News | February 06, 2015
February 6, 2015 — United States hospitals began using a new medical device from Medtronic plc  called the In.Pact...
drug-eluting balloons, DEB, ECRI, report, peripheral artery disease, PAD, cath

The Bard Lutonix drug-eluting balloon was cleared by the FDA last November.

Feature | January 30, 2015
January 30, 2015 — ECRI Institute has created a report that offers an overview of drug-eluting balloon (DEB) technology...
Balloon catheters, Heart Valve repair, Cath Lab, Hybrid OR

Image courtesy of InterValve

Technology | January 28, 2015
January 28, 2015 — Maquet Medical Systems USA announced an agreement to serve as the exclusive U.S. distributor of...